Duration of antibiotic treatment for Gram-negative bacteremia – Systematic review and individual participant data (IPD) meta-analysis
Adi Turjeman(Rabin Medical Center), Dafna Yahav(Sheba Medical Center), Leonard Leibovici(Tel Aviv University), Erica Franceschini(University of Modena and Reggio Emilia), Yael Dishon‐Benattar(Technion – Israel Institute of Technology), Jesús Rodríguez‐Baño(Hospital Universitario Virgen Macarena), Angela Huttner(University Hospital of Geneva), Mical Paul(Technion – Israel Institute of Technology), Dana Yelin(Sheba Medical Center), Cristina Mussini(University of Modena and Reggio Emilia), Fidi Koppel(Rambam Health Care Campus), José Miguel Cisneros(Instituto de Salud Carlos III), José Molina(Centre for Biomedical Network Research on Rare Diseases), Elodie von Dach(University Hospital of Geneva)
Cited by 61
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
|Clinical Microbiology and Infection|2021|1k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis
|Antimicrobial Agents and Chemotherapy|2010|727
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
|Clinical Microbiology Reviews|2018|688